BJSM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braham, R
Right arrow Articles by McNaughton, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braham, R
Right arrow Articles by McNaughton, L
Br J Sports Med 2003;37:45-49
© 2003 BMJ Publishing Group & British Association of Sport and Exercise Medicine


ORIGINAL ARTICLE

The effect of glucosamine supplementation on people experiencing regular knee pain

R Braham1, B Dawson1, C Goodman1

1 Department of Human Movement and Exercise Science, University of Western Australia, Crawley, Western Australia 6009

Correspondence to:
Correspondence to:
R Braham, Monash University, Department of Epidemiology and Preventive Medicine, Central and Eastern Clinical School, Alfred Hospital, Prahran VIC 3181, Australia;
Rebecca.Braham{at}med.monash.edu.au

Objective: The purpose of this study was to examine the effects of oral glucosamine supplementation on the functional ability and degree of pain felt by individuals who had regular knee pain, most likely due to previous articular cartilage damage, and possibly osteoarthritis.

Methods: Subjects were randomly supplemented with either glucosamine (G) (n=24) or placebo (P) (lactose) (n=22) for 12 weeks at a dose of 2000 mg per day. Over this period, four testing sessions were conducted, with changes in knee pain and function assessed by clinical and functional tests, (joint line palpation, a 3 metre "duck walk" and a repeated, walking stair climb), two questionnaires (the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Knee Pain Scale (KPS)) and participant subjective evaluations.

Results: The clinical and functional test scores improved with time (main effects: p<0.05, p<0.01) but there were no significant differences between the two groups. The questionnaire results also recorded a significant main effect for time (p<0.05), but the glucosamine group was found to have significantly better KOOS quality of life scores at week eight and 12 (p<0.05), and lower KPS scores (p<0.05) at week eight than the placebo group. On self report evaluations of changes across the 12 week supplementation period, 88% (n=21) of the glucosamine group reported some degree of improvement in their knee pain versus only 17% (n=3) in the placebo group.

Conclusions: These results suggest that glucosamine supplementation can provide some degree of pain relief and improved function in persons who experience regular knee pain, which may be caused by prior cartilage injury and/or osteoarthritis. The trends in the results also suggest that, at a dosage of 2000 mg per day, the majority of improvements are present after eight weeks.


Keywords: glucosamine; knee pain; cartilage damage; osteoarthritis


 

Commentary

L McNaughton2

2 Exercise Physiologist and Director of Postgraduate Studies, University of Bath, Claverton Down, Bath BA2 7AY, UK; l.mcnaughton{at}bath.ac.uk




This article has been cited by other articles:


Home page
Br. J. Sports. Med.Home page
A. N Bennett, K. M Crossley, P. D Brukner, and R. S Hinman
Predictors of symptomatic response to glucosamine in knee osteoarthritis: an exploratory study
Br. J. Sports Med., July 1, 2007; 41(7): 415 - 419.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine